Search Results

There are 55353 results for: content related to: MRI of trabecular bone using a decay due to diffusion in the internal field contrast imaging sequence

  1. Influence of bone marrow composition on measurements of trabecular microstructure using decay due to diffusion in the internal field MRI: Simulations and clinical studies

    Magnetic Resonance in Medicine

    Volume 72, Issue 6, December 2014, Pages: 1499–1508, Sara M. Sprinkhuizen, Jerome L. Ackerman and Yi-Qiao Song

    Version of Record online : 31 DEC 2013, DOI: 10.1002/mrm.25061

  2. You have free access to this content
    Diffusion-based MR methods for bone structure and evolution

    Magnetic Resonance in Medicine

    Volume 59, Issue 1, January 2008, Pages: 28–39, E.E. Sigmund, H. Cho, P. Chen, S. Byrnes, Y.-Q. Song, X.E. Guo and T. R. Brown

    Version of Record online : 20 DEC 2007, DOI: 10.1002/mrm.21281

  3. DDI Risk Assessment and Evaluation in Pharmaceutical Development: Interfacing Drug Metabolism and Clinical Pharmacology

    Standard Article

    Encyclopedia of Drug Metabolism and Interactions

    Karthik Venkatakrishnan

    Published Online : 15 OCT 2012, DOI: 10.1002/9780470921920.edm118

  4. Monographs for Drug-Drug Interactions of Therapeutics Biologics

    Standard Article

    Pharmaceutical Sciences Encyclopedia

    Jocelyn Leu, Simone Kasek, Christine Li, Wararat Limothai, Dora Babu Madhura, Chetan Rathi, Sumit Rawal, Josiah Ryman, Margaret Thomson, Ashit Trivedi, Honghui Zhou and Bernd Meibohm

    Published Online : 19 JUN 2013, DOI: 10.1002/9780470571224.pse487

  5. High-resolution MRI of internal field diffusion-weighting in trabecular bone

    NMR in Biomedicine

    Volume 22, Issue 4, May 2009, Pages: 436–448, E.E. Sigmund, H. Cho and Y.-Q. Song

    Version of Record online : 20 NOV 2008, DOI: 10.1002/nbm.1354

  6. You have free access to this content
    The retroviral proteinase active site and the N-terminus of Ddi1 are required for repression of protein secretion

    FEBS Letters

    Volume 585, Issue 1, January 03, 2011, Pages: 139–142, Rhian E. White, J. Richard Dickinson, Colin A.M. Semple, David J. Powell and Colin Berry

    Version of Record online : 19 NOV 2010, DOI: 10.1016/j.febslet.2010.11.026

  7. Quantitative Analyses of Hepatic OATP-Mediated Interactions Between Statins and Inhibitors Using PBPK Modeling With a Parameter Optimization Method

    Clinical Pharmacology & Therapeutics

    T Yoshikado, K Yoshida, N Kotani, T Nakada, R Asaumi, K Toshimoto, K Maeda, H Kusuhara and Y Sugiyama

    Version of Record online : 28 JUL 2016, DOI: 10.1002/cpt.391

  8. Drug–drug interactions in the medical intensive care unit: an assessment of frequency, severity and the medications involved

    International Journal of Pharmacy Practice

    Volume 20, Issue 6, December 2012, Pages: 402–408, Pamela L. Smithburger, Sandra L. Kane-Gill and Amy L. Seybert

    Version of Record online : 7 JUN 2012, DOI: 10.1111/j.2042-7174.2012.00221.x

  9. Incidence and Contributors to Potential Drug-Drug Interactions in Hospitalized Patients

    The Journal of Clinical Pharmacology

    Volume 51, Issue 7, July 2011, Pages: 1043–1050, Dr Leanne Reimche, Dr Alan J. Forster and Dr Carl van Walraven

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010378858

  10. Recommendations for Generating, Evaluating, and Implementing Drug-Drug Interaction Evidence

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 4, April 2012, Pages: 304–313, Lisa E. Hines, Daniel C. Malone and John E. Murphy

    Version of Record online : 27 MAR 2012, DOI: 10.1002/j.1875-9114.2012.01024.x

  11. Simulation of Metabolic Drug–Drug Interactions Perpetrated by Fluvoxamine Using Hybridized Two-Compartment Hepatic Drug-Pool-Based Tube Modeling and Estimation of In Vivo Inhibition Constants

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 10, October 2015, Pages: 3565–3577, Katsumi Iga

    Version of Record online : 22 JUN 2015, DOI: 10.1002/jps.24549

  12. Destruction of DDIT3/CHOP Protein by Wild-Type SPOP but Not Prostate Cancer-Associated Mutants

    Human Mutation

    Volume 35, Issue 9, September 2014, Pages: 1142–1151, Pingzhao Zhang, Kun Gao, Yan Tang, Xiaofeng Jin, Jian An, Hongxiu Yu, Huan Wang, Yuanyuan Zhang, Dejie Wang, Haojie Huang, Long Yu and Chenji Wang

    Version of Record online : 23 JUL 2014, DOI: 10.1002/humu.22614

  13. You have free access to this content
    Interdependent Nucleocytoplasmic Trafficking and Interactions of Dis3 with Rrp6, the Core Exosome and Importin-α3

    Traffic

    Volume 10, Issue 5, May 2009, Pages: 499–513, Amy C. Graham, Stephanie M. Davis and Erik D. Andrulis

    Version of Record online : 11 FEB 2009, DOI: 10.1111/j.1600-0854.2009.00888.x

  14. Hippocampal-like circuitry in the pallium of an electric fish: Possible substrates for recursive pattern separation and completion

    Journal of Comparative Neurology

    S. Benjamin Elliott, Erik Harvey-Girard, Ana C.C. Giassi and Leonard Maler

    Version of Record online : 26 JUN 2016, DOI: 10.1002/cne.24060

  15. Relevance of translocation type in myxoid liposarcoma and identification of a novel EWSR1-DDIT3 fusion

    Genes, Chromosomes and Cancer

    Volume 46, Issue 11, November 2007, Pages: 961–971, B. Bode-Lesniewska, S. Frigerio, U. Exner, M. T. Abdou, H. Moch and D. R. Zimmermann

    Version of Record online : 23 JUL 2007, DOI: 10.1002/gcc.20478

  16. You have free access to this content
    Intestinal transporters for endogenic and pharmaceutical organic anions: the challenges of deriving in-vitro kinetic parameters for the prediction of clinically relevant drug–drug interactions

    Journal of Pharmacy and Pharmacology

    Volume 64, Issue 11, November 2012, Pages: 1523–1548, Anne Sophie Grandvuinet, Henrik Tang Vestergaard, Nicolas Rapin and Bente Steffansen

    Version of Record online : 29 MAR 2012, DOI: 10.1111/j.2042-7158.2012.01505.x

  17. Regulatory mechanisms, expression levels and proliferation effects of the FUS–DDIT3 fusion oncogene in liposarcoma

    The Journal of Pathology

    Volume 238, Issue 5, April 2016, Pages: 689–699, Pierre Åman, Soheila Dolatabadi, David Svec, Emma Jonasson, Setareh Safavi, Daniel Andersson, Pernilla Grundevik, Christer Thomsen and Anders Ståhlberg

    Version of Record online : 17 MAR 2016, DOI: 10.1002/path.4700

  18. You have free access to this content
    Do Children Have the Same Vulnerability to Metabolic Drug–Drug Interactions as Adults? A Critical Analysis of the Literature

    The Journal of Clinical Pharmacology

    Volume 53, Issue 5, May 2013, Pages: 559–566, Farzaneh Salem, Amin Rostami-Hodjegan and Trevor N. Johnson

    Version of Record online : 20 FEB 2013, DOI: 10.1002/jcph.13

  19. Damage detection in structures using a transmissibility-based Mahalanobis distance

    Structural Control and Health Monitoring

    Volume 22, Issue 10, October 2015, Pages: 1209–1222, Yun-Lai Zhou, E. Figueiredo, N. Maia, R. Sampaio and R. Perera

    Version of Record online : 27 FEB 2015, DOI: 10.1002/stc.1743

  20. You have free access to this content
    Myxoid liposarcoma FUS-DDIT3 fusion oncogene induces C/EBP β-mediated interleukin 6 expression

    International Journal of Cancer

    Volume 115, Issue 4, 1 July 2005, Pages: 556–560, Melker Göransson, Erik Elias, Anders Ståhlberg, Anita Olofsson, Carola Andersson and Pierre Åman

    Version of Record online : 1 FEB 2005, DOI: 10.1002/ijc.20893